Gainers & Losers
Mon Nov 25 2024 10:23:34- Larsen & Toubro share price
- ₹3,753.254.13%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
- Wipro share price
- ₹582.751.99%
- ICICI Bank share price
- ₹1,301.501.82%
Active Stocks
Mon Nov 25 2024 10:27:51- Adani Power share price
- ₹446.85-3.02%
- Power Grid Corporation Of ...
- ₹342.851.74%
- Tata Steel share price
- ₹143.600.56%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
Business News/Market/Market Stats/Strides Pharma Science share price/ Strides Pharma Science Balance Sheet Annual
Strides Pharma Science Balance Sheet Annual
Trade1,419.15 -84.60 (-5.63%)Updated : 25 Nov 2024
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Cash Equivalents | 191.17 | 190.96 | 1.46 | 0.53 |
| Short Term Investments | 225.27 | 57.20 | 13.46 | 149.03 |
| Cashand Short Term Investments | 416.43 | 360.70 | 184.19 | 274.87 |
| Accounts Receivable- Trade Net | 1,141.87 | 1,301.55 | 1,207.97 | 1,112.26 |
| Total Receivables Net | 1,154.61 | 1,500.51 | 1,889.85 | 1,245.41 |
| Total Inventory | 1,126.24 | 1,200.37 | 1,229.54 | 1,233.50 |
| Other Current Assets Total | 271.72 | 117.85 | 4.08 | 10.77 |
| Total Current Assets | 2,969.00 | 3,243.36 | 3,361.83 | 2,817.23 |
| Property/ Plant/ Equipment Total- Gross | 79.88 | 2,094.34 | 2,159.90 | 2,000.82 |
| Property/ Plant/ Equipment Total- Net | 958.55 | 1,372.55 | 1,513.64 | 1,499.45 |
| Goodwill Net | 529.41 | 513.76 | 485.91 | 480.54 |
| Intangibles Net | 527.12 | 563.09 | 624.98 | 618.51 |
| Long Term Investments | 400.49 | 459.00 | 560.52 | 1,207.03 |
| Note Receivable- Long Term | 163.59 | 183.77 | 172.51 | 188.31 |
| Other Long Term Assets Total | 291.60 | 302.89 | 256.47 | 203.95 |
| Total Assets | 5,839.76 | 6,638.42 | 6,975.86 | 7,015.02 |
| Accounts Payable | 851.59 | 982.34 | 1,071.52 | 1,178.62 |
| Current Portof LT Debt/ Capital Leases | 1,773.73 | 355.34 | 506.40 | 231.54 |
| Other Currentliabilities Total | 253.94 | 260.52 | 280.35 | 299.56 |
| Total Current Liabilities | 2,879.26 | 2,990.20 | 3,411.68 | 2,738.35 |
| Long Term Debt | 671.50 | 1,139.79 | 835.62 | 882.58 |
| Capital Lease Obligations | 71.64 | 203.67 | 186.47 | 210.27 |
| Total Long Term Debt | 743.13 | 1,343.47 | 1,022.09 | 1,092.85 |
| Total Debt | 2,516.87 | 3,029.57 | 3,025.03 | 2,348.23 |
| Deferred Income Tax | 40.35 | 44.57 | 35.72 | 46.35 |
| Minority Interest | -53.86 | -39.38 | 24.09 | 37.34 |
| Other Liabilities Total | 105.31 | 87.30 | 123.06 | 323.48 |
| Total Liabilities | 3,714.19 | 4,426.16 | 4,616.63 | 4,238.36 |
| Common Stock Total | 91.90 | 90.30 | 89.79 | 89.68 |
| Retained Earnings( Accumulated Deficit) | 2,033.66 | 307.26 | 484.85 | 952.18 |
| Total Equity | 2,125.56 | 2,212.26 | 2,359.23 | 2,776.66 |
| Total Liabilities Shareholders' Equity | 5,839.76 | 6,638.42 | 6,975.86 | 7,015.02 |
| Total Common Shares Outstanding | 9.19 | 9.03 | 8.98 | 8.97 |
| Tangible Book Valueper Share Common Eq | 116.33 | 125.73 | 139.03 | 187.06 |
| Cash | - | 112.54 | 169.27 | 125.31 |
| Prepaid Expenses | - | 63.93 | 54.19 | 52.69 |
| Accumulated Depreciation Total | - | -721.79 | -646.25 | -501.37 |
| Accrued Expenses | - | 61.23 | 56.87 | 4.79 |
| Notes Payable/ Short Term Debt | - | 1,330.76 | 1,496.53 | 1,023.84 |
| Additional Paid- In Capital | - | 1,754.45 | 1,732.59 | 1,727.27 |
| ESOP Debt Guarantee | - | 2.32 | 2.05 | 4.72 |
| Unrealized Gain( Loss) | - | -130.00 | -67.21 | -59.88 |
| Other Equity Total | - | 187.94 | 117.16 | 62.69 |
*All figures in crores except per share values
Strides Pharma Science Quick Links
Strides Pharma Science Dividend Strides Pharma Science Bonus Strides Pharma Science News Strides Pharma Science AGM Strides Pharma Science Rights Strides Pharma Science Splits Strides Pharma Science Board Meetings Strides Pharma Science Key Metrics Strides Pharma Science Shareholdings Strides Pharma Science Profit Loss Strides Pharma Science Cashflow Strides Pharma Science Q1 Results Strides Pharma Science Q2 Results Strides Pharma Science Q3 Results Strides Pharma Science Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,753.25+148.70(4.13%)
844.75+28.70(3.52%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)